Quality indicators for the use of systemic antibiotics in dentistry.

Z Evid Fortbild Qual Gesundhwes

AQUA - Institut für angewandte Qualitätsförderung und Forschung im Gesundheitswesen GmbH, Göttingen, Germany.

Published: May 2017

AI Article Synopsis

  • Risks associated with systemic antibiotic use, like increased resistance and side effects, must be evaluated on a patient-by-patient basis, making routine prescriptions inadvisable.
  • The G-BA tasked the AQUA-Institute to develop quality assurance procedures for antibiotic use in dental care to enhance patient safety and promote first-line medications.
  • An analysis of dental claims revealed that 4.7 million antibiotic prescriptions were issued for treatments, with only 3.4% given without proper indication, and penicillin and clindamycin comprised about 46.3% and 47.0% of prescriptions, respectively.

Article Abstract

Background: Risks resulted from using systemic antibiotics such as increasing rates of bacterial resistance, allergy and side effects should be always weighed individually for each patient against any potential benefits. Routine antibiotic prescribing must be therefore discouraged. The Federal Joint Committee ("Gemeinsamer Bundesauschuss", G-BA) commissioned the AQUA-Institute with the development of an external quality assurance procedure, examining systemic antibiotic use in periodontal, conservative and surgical treatments in ambulatory dental health care. The aim of the procedure was to increase patient safety through rational use of systemic antibiotics and increasing the use of first line medications.

Material And Methods: The process of developing the quality indicators included searching for relevant literature and quality indicators, analyzing dental claims data (2013) and antibiotic prescriptions, and finally evaluating the proposed quality indicators in an expert panel. The analysis examined patients who received dental treatments and a prescription for systemic antibiotics. The indicator set consisted of three indicators: usage of systemic antibiotics in dental treatments without indication for antibiotics, the percentage of penicillin prescriptions in dental treatments and the percentage of clindamycin prescriptions in dental treatments.

Results: The analysis showed that about 574 million claims on conservative and surgical treatments were made for about 60 million patients. In total, about 4.7 million systemic antibiotics prescriptions were issued for 3.5 million patients with dental treatments. The percentage of patients given a systemic antibiotic as an adjunct to dental treatments, usually without indication, was 3.4 %. The percentage of penicillin prescriptions (as a whole therapeutic/pharmacological subgroup) of the total systemic antibiotic use in dental treatments was 46.3 %; for clindamycin it was 47.0 %.

Conclusion: Clindamycin is preferred by German dentists, and its overprescription represents an inappropriate use of antibiotics. Optimizing antibiotics prescriptions in dental care through rational use decreases bacterial resistance, increases patient safety and the overall quality of dental care. Future analysis and reporting of the indicators will draw a clear picture of dental antibiotic use, i.e. using a risk adjustment for the first indicator and the implementation of a consistent identification system for dentists in the statutory health insurance (SHI). This will enable a direct connection between dentists and their respective antibiotic prescriptions (causal relationship) and thus highlight areas of need for quality improvement. As such targeted educational activities can be developed on an individual basis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.zefq.2017.04.007DOI Listing

Publication Analysis

Top Keywords

systemic antibiotics
24
dental treatments
24
quality indicators
16
systemic antibiotic
12
dental
12
prescriptions dental
12
systemic
9
antibiotics
9
antibiotics increasing
8
bacterial resistance
8

Similar Publications

In recent years, the importance of using local disinfectants instead of systemic antibiotics for the treatment of infectious skin diseases to prevent the emergence of resistant bacteria has become widely recognized. Chlorhexidine gluconate (CHG) is commonly used in veterinary antibacterial shampoos; however, the daily topical application of diluted CHG solutions has also been adopted. Despite its widespread use, few studies have investigated the effects of CHG on the canine skin barrier.

View Article and Find Full Text PDF

Kidney Targeting Smart Antibiotic Discovery: Multimechanism Pleuromutilins for Pyelonephritis Therapy.

J Med Chem

January 2025

Xi'an Key Laboratory for Antiviral and Antimicrobial-Resistant Bacteria Therapeutics Research, Xi'an 710021, China.

Multidrug-resistant (MDR) bacteria pose a global health threat, underscoring the need for new antibiotics. Lefamulin, the first novel-mechanism antibiotic approved by the FDA in decades, showcases pleuromutilins' promise due to low mutation frequency. However, their clinical use is limited by poor pharmacokinetics and organ toxicity.

View Article and Find Full Text PDF

This article focuses on two key innovations in dermatology: post-exposure prophylaxis for sexually transmitted infections (STIs) and new therapeutic options for inflammatory skin diseases. New European and American guidelines for doxycycline post-exposure prophylaxis (Doxy PEP) aim to prevent STIs in men who have sex with men (MSM) and individuals on HIV pre-exposure prophylaxis (PrEP). Doxy PEP is effective against syphilis and chlamydia, but its efficacy is limited by growing gonorrhea resistance.

View Article and Find Full Text PDF

Mycotic aneurysms are rare but severe complications that can arise from systemic bacterial infections, including those caused by Salmonella species. These aneurysms can progress rapidly and are associated with high mortality. A 62-year-old man with poorly controlled type 2 diabetes mellitus presented to the hospital in septic shock.

View Article and Find Full Text PDF

Background: Ecthyma is a deeper form of impetigo involving the epidermis and dermis causing ulcerative plaques. Pathogens commonly responsible for the disease (group A beta-hemolytic streptococcus and Staphylococcus aureus) typically afflicts children, presenting during early stages with skin lesions that can closely resemble other vesicular and ulcerative dermatoses, such as those observed in mpox infection. The ongoing global outbreak of monkeypox has escalated the urgency for clinicians to accurately differentiate between these conditions due to their overlapping dermatological manifestations.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!